Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/<i>β</i>-Cyclodextrin Nanocomposition against  Androgen Receptor-Negative Prostate Cancers

<table>Induction of new cell populations of activated peripheral blood mononuclear cells versus control (SSC-H:site scatter height, FSC-H:forward scatter height). (a) control ML, (b) LAK, (c) IL-2<sup>50</sup> cells, (d) CD cells, and (e) IL-2<sup>50</sup>/CD cells. </table>

International Scholarly Research Notices

fig7

Figure 7

Figure 7: Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/<i>β</i>-Cyclodextrin Nanocomposition against  Androgen Receptor-Negative Prostate Cancers 

Figure 7 | Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against  Androgen Receptor-Negative Prostate Cancers 